P/Il L Bvf Partners
10% Owner; Director, 10% Owner; Director, Other · 7 filings · Latest: Jun 26, 2026
Kymera Therapeutics, Inc.
MoonLake Immunotherapeutics
Olema Pharmaceuticals, Inc.
Repare Therapeutics Inc.
XOMA Royalty Corp
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
KYMR | P/Il L Bvf Partners | Director, Other | Jun 26, 2026 | Sale | $106.50 | 1,630,658 | $173.7M | 78,787 | |
KYMR | BVF PARTNERS L P/IL | — | Jun 26, 2026 | Proposed Sale | $116.46 | 1,630,658 | $189.9M | — | |
MLTX | P/Il L Bvf Partners | Director, 10% Owner | Mar 31, 2026 | Sale | $16.79 | 3,750,000 | $63.0M | 1,039,238 | |
MLTX | BVF PARTNERS L P/IL | — | Mar 31, 2026 | Proposed Sale | $16.93 | 3,750,000 | $63.5M | — |